Publications by authors named "Veronica Patton"

Claim this Profile
L
Long-term adaptation following influenza A virus host shifts results in increased within-host viral fitness due to higher replication rates, broader dissemination within the respiratory epithelium and reduced tissue damage.
Julien A R Amat, Veronica Patton, Caroline Chauché, Daniel Goldfarb, Joanna Crispell

PLoS Pathog· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular endothelial growth factor c promotes ovarian carcinoma progression through paracrine and autocrine mechanisms.
Alessandra Decio, Giulia Taraboletti, Veronica Patton, Rachele Alzani, Patrizia Perego

Am J Pathol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Polo-Like Kinase 1 (PLK1) inhibitor NMS-P937 is effective in a new model of disseminated primary CD56+ acute monoblastic leukaemia.
Alessia Casolaro, Josee Golay, Clara Albanese, Roberta Ceruti, Veronica Patton

PLoS One· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphorylation of TCTP as a marker for polo-like kinase-1 activity in vivo.
Ulisse Cucchi, Laura M Gianellini, Anna De Ponti, Francesco Sola, Rachele Alzani, Veronica Patton

Anticancer Res· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual targeting of CDK and tropomyosin receptor kinase families by the oral inhibitor PHA-848125, an agent with broad-spectrum antitumor efficacy.
Clara Albanese, Rachele Alzani, Nadia Amboldi, Nilla Avanzi, Dario Ballinari, Veronica Patton

Mol Cancer Ther· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic efficacy of the pan-cdk inhibitor PHA-793887 in vitro and in vivo in engraftment and high-burden leukemia models.
Rachele Alzani, Olga Pedrini, Clara Albanese, Roberta Ceruti, Alessia Casolaro, Veronica Patton

Exp Hematol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of PHA-848125, a cyclin-dependent kinase inhibitor, on the K-Ras(G12D)LA2 lung adenocarcinoma transgenic mouse model: evaluation by multimodality imaging.
Anna Degrassi, Micaela Russo, Cristina Nanni, Veronica Patton, Rachele Alzani

Mol Cancer Ther· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced mammary tumor progression in a transgenic mouse model fed an isoflavone-poor soy protein concentrate.
Giulia Chiesa, Elena Rigamonti, Maria R Lovati, Emanuela Disconzi, Sabina Soldati, Veronica Patton

Mol Nutr Food Res· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity.
Alessia Montagnoli, Barbara Valsasina, Valter Croci, Maria Menichincheri, Sonia Rainoldi, Veronica Patton

Nat Chem Biol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer.
Patrizia Carpinelli, Roberta Ceruti, Maria Laura Giorgini, Paolo Cappella, Laura Gianellini, Veronica Patton

Mol Cancer Ther· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis